{
  "@context": "aku-v2",
  "@type": "definition",
  "@id": "wsmg:health-sciences/medicine/nephrology/neph-028",
  "metadata": {
    "version": "4.0.0",
    "created": "2026-01-09T01:53:50.000Z",
    "modified": "2026-01-13T14:36:00.000Z",
    "contributors": [
      "copilot-agent",
      "quality-enhancement-agent",
      "quality-agent"
    ],
    "confidence": 0.96,
    "status": "validated",
    "language": "en",
    "licenses": ["CC-BY-4.0"]
  },
  "classification": {
    "domain_path": "health-sciences/medicine/nephrology",
    "subdomain": "cardiorenal_medicine",
    "type": "definition",
    "difficulty": "advanced",
    "importance": "high",
    "isNativeDomain": true,
    "board_yield": "MEDIUM"
  },
  "content": {
    "title": "Cardiorenal Syndrome",
    "summary": "Cardiorenal syndrome (CRS) describes the bidirectional pathophysiologic interplay between heart and kidney dysfunction, where acute or chronic dysfunction of one organ induces dysfunction in the other. The Ronco classification identifies 5 types based on the primary failing organ and acuity, guiding diagnosis and targeted therapy.",
    "key_points": [
      "Type 1: Acute HF causes acute kidney injury (most common in hospitalized patients)",
      "Type 2: Chronic HF leads to progressive CKD",
      "Type 3: Acute kidney injury precipitates acute cardiac dysfunction",
      "Type 4: CKD contributes to cardiac hypertrophy, dysfunction, and increased CV events",
      "Type 5: Systemic conditions (sepsis, amyloid) affect both organs simultaneously",
      "Diuretic resistance is a hallmark challenge requiring combination strategies"
    ],
    "statement": "Cardiorenal syndrome is a pathophysiologic disorder of heart and kidneys whereby acute or chronic dysfunction in one organ may induce acute or chronic dysfunction in the other, classified into five types based on the primary organ affected and temporal sequence.",
    "explanation": {
      "intuition": "Heart and kidney are intimately linked through blood pressure, volume status, and neurohormonal activation. When one fails, it drags the other down - heart failure reduces renal perfusion and causes congestion, while kidney failure causes volume overload and toxin accumulation that stresses the heart.",
      "key_insight": "The key conceptual shift is recognizing that rising creatinine in heart failure is often due to venous congestion, not just poor arterial perfusion. Central venous pressure elevation increases renal interstitial pressure and impairs glomerular filtration - hence, decongestion may actually improve kidney function.",
      "technical_details": "Mechanisms include reduced cardiac output (decreased renal perfusion), elevated CVP (increased renal venous pressure), neurohormonal activation (RAAS, SNS), and cardiorenal connectors (adenosine, FGF-23, uremic toxins). Diuretic resistance in CRS involves reduced tubular delivery, increased sodium avidity, and impaired response to natriuretic peptides."
    },
    "definitions_glossary": {
      "cardiorenal_syndrome": "Pathophysiologic disorders involving heart and kidney where dysfunction in one induces dysfunction in the other",
      "CRS_type_1": "Acute HF causing AKI; most common in ADHF hospitalizations",
      "CRS_type_2": "Chronic HF leading to progressive CKD",
      "CRS_type_3": "AKI causing acute cardiac dysfunction (arrhythmias, pulmonary edema)",
      "CRS_type_4": "CKD causing chronic cardiac disease (LVH, diastolic dysfunction)",
      "CRS_type_5": "Systemic conditions causing simultaneous cardiac and renal dysfunction",
      "diuretic_resistance": "Failure to achieve adequate decongestion despite escalating diuretic doses",
      "venous_congestion": "Elevated CVP causing increased renal interstitial pressure and reduced GFR",
      "RAAS_activation": "Neurohormonal response to perceived hypovolemia worsening sodium retention",
      "ultrafiltration": "Mechanical fluid removal via continuous venovenous hemofiltration",
      "worsening_renal_function": "Serum creatinine increase â‰¥0.3 mg/dL during HF treatment",
      "cardiorenal_connectors": "Mediators linking heart and kidney dysfunction (ANP, BNP, FGF-23, uremic toxins)",
      "low_output_syndrome": "Reduced cardiac output causing prerenal AKI"
    }
  },
  "clinical_features": {
    "pathophysiology": {
      "mechanism": "Bidirectional interaction through hemodynamic, neurohormonal, and inflammatory pathways",
      "hemodynamic_factors": {
        "forward_failure": "Reduced cardiac output decreases renal perfusion pressure",
        "backward_failure": "Elevated CVP increases renal venous pressure, causing congestion",
        "intra_abdominal_hypertension": "Ascites and splanchnic congestion compress renal vasculature"
      },
      "neurohormonal_activation": {
        "RAAS": "Angiotensin II causes vasoconstriction and sodium retention",
        "sympathetic_nervous_system": "Increases renal vascular resistance",
        "ADH": "Promotes water retention and hyponatremia"
      },
      "cardiorenal_connectors": [
        "Adenosine (tubuloglomerular feedback)",
        "FGF-23 (uremic toxin causing LVH)",
        "Indoxyl sulfate, p-cresol (uremic toxins)",
        "Natriuretic peptides (impaired action in CKD)"
      ]
    },
    "diagnostic_criteria": {
      "Ronco_classification": {
        "type_1": {
          "primary_event": "Acute heart failure",
          "secondary": "Acute kidney injury",
          "timing": "Hours to days",
          "examples": ["ADHF with AKI", "Cardiogenic shock", "Acute MI with AKI"]
        },
        "type_2": {
          "primary_event": "Chronic heart failure",
          "secondary": "Progressive CKD",
          "timing": "Months to years",
          "examples": ["HFrEF with declining eGFR over time"]
        },
        "type_3": {
          "primary_event": "Acute kidney injury",
          "secondary": "Acute cardiac dysfunction",
          "timing": "Hours to days",
          "examples": ["AKI causing pulmonary edema, arrhythmias, or pericarditis"]
        },
        "type_4": {
          "primary_event": "Chronic kidney disease",
          "secondary": "Chronic cardiac disease",
          "timing": "Months to years",
          "examples": ["CKD with LVH, coronary disease, heart failure"]
        },
        "type_5": {
          "primary_event": "Systemic condition",
          "secondary": "Both cardiac and renal dysfunction",
          "examples": ["Sepsis", "Amyloidosis", "Diabetes mellitus", "Cirrhosis"]
        }
      },
      "diagnostic_markers": [
        "Serum creatinine, BUN, eGFR",
        "BNP/NT-proBNP (elevated; confounded by GFR)",
        "Troponin (may elevate in CKD without ACS)",
        "Urine sodium, FENa (distinguish prerenal)",
        "CVP measurement or IVC assessment"
      ]
    },
    "differential_diagnosis": [
      "Pre-renal AKI from volume depletion vs cardiorenal",
      "Intrinsic renal disease coincident with heart failure",
      "Drug-induced nephrotoxicity (contrast, NSAIDs)",
      "Atherosclerotic renovascular disease"
    ],
    "treatment_options": {
      "type_1_acute_HF_AKI": {
        "decongestion": {
          "loop_diuretics": "IV furosemide; continuous infusion if bolus-resistant",
          "combination_therapy": "Add thiazide (metolazone) for diuretic resistance",
          "dopamine": "Low-dose no longer recommended",
          "ultrafiltration": "Consider if refractory to pharmacologic diuresis"
        },
        "optimize_hemodynamics": [
          "Vasodilators (nitroprusside, nesiritide) if adequate BP",
          "Inotropes (dobutamine, milrinone) for low-output states"
        ],
        "avoid_nephrotoxins": ["Hold NSAIDs, aminoglycosides, contrast"]
      },
      "type_2_chronic_HF_CKD": {
        "GDMT_optimization": [
          "ACE-I/ARB (tolerate up to 30% Cr rise if stable)",
          "SGLT2 inhibitors (nephroprotective and cardioprotective)",
          "MRA (spironolactone/eplerenone with K monitoring)"
        ],
        "volume_management": "Diuretics titrated to euvolemia",
        "advanced_therapies": "Consider CRT, LVAD, or transplant evaluation"
      },
      "type_3_AKI_cardiac": {
        "treat_underlying_AKI": "Relieve obstruction, stop nephrotoxins, treat sepsis",
        "manage_hyperkalemia": "Emergent if arrhythmias (calcium, insulin/glucose, dialysis)",
        "volume_management": "Dialysis/ultrafiltration for pulmonary edema"
      },
      "type_4_CKD_cardiac": {
        "CV_risk_reduction": "Statins, BP control, glycemic control",
        "anemia_management": "ESAs if Hgb <10 g/dL (target 10-11.5)",
        "mineral_metabolism": "Phosphate binders, vitamin D, calcimimetics"
      }
    }
  },
  "skos": {
    "prefLabel": {
      "@language": "en",
      "@value": "Cardiorenal Syndrome"
    },
    "altLabel": [
      {"@language": "en", "@value": "CRS"},
      {"@language": "en", "@value": "Heart-kidney syndrome"},
      {"@language": "en", "@value": "Renocardiac syndrome"}
    ],
    "definition": {
      "@language": "en",
      "@value": "A pathophysiologic disorder of the heart and kidneys whereby acute or chronic dysfunction in one organ may induce acute or chronic dysfunction in the other"
    },
    "notation": "neph-028",
    "scopeNote": {
      "@language": "en",
      "@value": "Covers the Ronco classification of cardiorenal syndrome types 1-5 with pathophysiology and management strategies"
    }
  },
  "relationships": {
    "skos:broader": [
      {
        "@id": "wsmg:health-sciences/medicine/nephrology/organ-crosstalk",
        "skos:prefLabel": "Organ Crosstalk Syndromes"
      }
    ],
    "skos:related": [
      {
        "@id": "wsmg:health-sciences/medicine/cardiology/heart-failure",
        "skos:prefLabel": "Heart Failure"
      },
      {
        "@id": "wsmg:health-sciences/medicine/nephrology/neph-001",
        "skos:prefLabel": "Acute Kidney Injury"
      },
      {
        "@id": "wsmg:health-sciences/medicine/nephrology/neph-029",
        "skos:prefLabel": "Hepatorenal Syndrome"
      }
    ],
    "owl:sameAs": [
      "http://dbpedia.org/resource/Cardiorenal_syndrome"
    ]
  },
  "medicalCode": [
    {
      "@type": "MedicalCode",
      "codingSystem": "SNOMED-CT",
      "codeValue": "722095005",
      "uri": "http://snomed.info/id/722095005",
      "description": "Cardiorenal syndrome"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "ICD-10-CM",
      "codeValue": "I13.10",
      "uri": "http://hl7.org/fhir/sid/icd-10-cm/I13.10",
      "description": "Hypertensive heart and chronic kidney disease"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "MeSH",
      "codeValue": "D059347",
      "uri": "http://id.nlm.nih.gov/mesh/D059347",
      "description": "Cardio-Renal Syndrome"
    }
  ],
  "pedagogical": {
    "learning_objectives": [
      "Classify cardiorenal syndrome using the Ronco 5-type classification",
      "Explain the bidirectional pathophysiology linking heart and kidney dysfunction",
      "Recognize that venous congestion, not just low output, causes renal dysfunction in HF",
      "Develop management strategies for diuretic resistance in CRS type 1",
      "Apply appropriate therapies for each CRS type"
    ],
    "clinical_pearls": [
      "Rising Cr in HF may be from venous congestion - decongestion can improve GFR",
      "Tolerate up to 30% Cr rise on ACE-I/ARB if patient remains stable",
      "Diuretic resistance: add thiazide, consider continuous infusion, or ultrafiltration",
      "SGLT2i are beneficial in both HF and CKD - cornerstone of cardiorenal protection",
      "BNP interpretation must account for GFR - values are higher with lower eGFR"
    ],
    "board_yield": "MEDIUM",
    "estimated_time": "30min",
    "target_audience": [
      "internal_medicine_residents",
      "nephrology_fellows",
      "cardiology_fellows",
      "hospitalists"
    ],
    "common_misconceptions": [
      "Rising creatinine always means stop diuretics - may actually need more diuresis",
      "CRS is always due to low cardiac output - venous congestion is often the driver",
      "Ultrafiltration is always better than diuretics - CARRESS-HF showed no benefit"
    ]
  },
  "prerequisites": [
    {
      "@id": "wsmg:health-sciences/medicine/nephrology/neph-001",
      "skos:prefLabel": "Acute Kidney Injury"
    },
    {
      "@id": "wsmg:health-sciences/medicine/cardiology/cardio-004",
      "skos:prefLabel": "Heart Failure Classification"
    }
  ],
  "related_concepts": [
    "heart failure",
    "acute kidney injury",
    "diuretic therapy",
    "hemodynamic monitoring"
  ],
  "evidence": {
    "citations": [
      {
        "authors": "Ronco C, Haapio M, House AA, et al.",
        "title": "Cardiorenal syndrome",
        "journal": "J Am Coll Cardiol",
        "year": 2008,
        "volume": "52",
        "pages": "1527-1539",
        "doi": "10.1016/j.jacc.2008.07.051"
      },
      {
        "authors": "Bart BA, Goldsmith SR, Lee KL, et al.",
        "title": "Ultrafiltration in decompensated heart failure with cardiorenal syndrome (CARRESS-HF)",
        "journal": "N Engl J Med",
        "year": 2012,
        "volume": "367",
        "pages": "2296-2304",
        "doi": "10.1056/NEJMoa1210357"
      }
    ],
    "confidence_rationale": "Based on established Ronco classification and major clinical trials"
  },
  "provenance": {
    "verification_status": "verified",
    "last_verified": "2026-01-13T14:36:00.000Z",
    "sources": [
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed.",
        "type": "textbook",
        "year": 2022,
        "isbn": "978-1264268504",
        "relevance": "Standard internal medicine reference"
      },
      {
        "source": "JACC State-of-the-Art Review: Cardiorenal Syndrome",
        "type": "journal",
        "year": 2019,
        "relevance": "Comprehensive review of CRS pathophysiology and management"
      }
    ]
  },
  "quality_assessment": {
    "content_quality_score": 0.93,
    "completeness": 0.94,
    "accuracy": 0.95,
    "clarity": 0.92,
    "clinical_relevance": 0.95,
    "last_assessed": "2026-01-13T14:36:00.000Z"
  },
  "owl:sameAs": "http://dbpedia.org/resource/Cardiorenal_syndrome",
  "skos:exactMatch": "http://www.wikidata.org/entity/Q5038392"
}